Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detection of Hypoxia in Human Thoracic Aorta Using Pimonidazole Hydrochloride
NCT03410420Phase 1Completed
- Start
- Sep 2018
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of pimonidazole in thoracic aortic aneurysm (TAA) (2 arms). Primary endpoint: Detection of pimonidazole-HCl in aortic specimens. Started Sep 2018; status: completed.
02
Drugs
pimonidazole
03
Conditions
thoracic aortic aneurysm (TAA)
Beyond the preview
Go deeper on NCT03410420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03410420.